Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.55 -0.02 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.57 | 52 Week High | $1.11 | |||
| Open | $2.54 | 52 Week Low | $0.41 | |||
| Day High | $2.56 | P/E | N/A | |||
| Day Low | $2.50 | EPS | $-0.29 | |||
| Volume | 383,909 | |||||
